SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-093122
Filing Date
2023-12-05
Accepted
2023-12-05 16:05:17
Documents
14
Period of Report
2023-12-04
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea189550-8k_silopharma.htm   iXBRL 8-K 28045
2 CERTIFICATE OF AMENDMENT ea189550ex3-1_silopharma.htm EX-3.1 451
3 GRAPHIC ex3-1.jpg GRAPHIC 499059
  Complete submission text file 0001213900-23-093122.txt   889716

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE silo-20231204.xsd EX-101.SCH 3021
5 XBRL LABEL FILE silo-20231204_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE silo-20231204_pre.xml EX-101.PRE 22363
8 EXTRACTED XBRL INSTANCE DOCUMENT ea189550-8k_silopharma_htm.xml XML 3322
Mailing Address 560 SYLVAN AVE SUITE 3160 ENGLEWOOD CLIFFS NJ 07632
Business Address 560 SYLVAN AVE SUITE 3160 ENGLEWOOD CLIFFS NJ 07632 (718) 400-9031
Silo Pharma, Inc. (Filer) CIK: 0001514183 (see all company filings)

IRS No.: 462137136 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41512 | Film No.: 231466551
SIC: 2300 Apparel & Other Finishd Prods of Fabrics & Similar Matl